Advertisement
Cardiometabolic Risk

James Matera, DO, on Managing Comorbid CVD, Diabetes, and Kidney Disease

04/22/2020

James Matera, DO, from CentraState Medical Center, explains why CVD, diabetes, and kidney disease often occur together, and how the presence of one or more of these conditions can complicate treatment outcomes. He also discusses how the 2017 ACC/AHA hypertension guideline has impacted disease management in this patient population.

For more, visit our Diabetes and Nephrology Resource Centers.

James J. Matera, DO, FACOI, is a nephrologist and Medical Director of Population Health at CentraState Medical Center in Freehold, New Jersey.

References:

1. de Boer IH, Sun W, Cleary PA, et al; DCCT/EDIC Research Group. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med. 2011;365:2366-2376. doi:10.1056/NEJMoa1111732.

2. Rosenstock J, Perkovic V, Johanssen OE, et al. Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: The CARMELINA Randomized Clinical Trial. JAMA. 2019;321(1):69-79. doi:10.1001/jama.2018.18269.

3. Das SR, Everett BM, Birtcher KK, et al. 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: A report of the American College of Cardiology Task Force on expert consensus decision pathways. J Am Coll Cardiol. 2018. doi:10.1016/j.jacc.2018.09.020.

4. Carey RM, Whelton PK; 2017 ACC/AHA Hypertension Guideline Writing Committee. Prevention, detection, evaluation, and management of high blood pressure in adults: Synopsis of the 2017 American College of Cardiology/American Heart Association hypertension guideline. Ann Intern Med. 2018;168(5):351-358. doi:10.7326/M17-3203.

Related Content

Hepatology
Hepatology
Jorge Herrera, MD, on a Guide for Screening, Referring, and Treating Patients With HCV
12/17/2018
Jorge Herrera, MD director of the Section of Hepatology and professor of Internal Medicine at the University of South Alabama, discusses screening, referring, and managing patients with hepatitis C virus. ...
12/17/2018
Diabetes
Diabetes
Jacob Sands, MD, on Lung Cancer Stigma
11/01/2019
He discusses lung cancer stigma, how it affects patient outcomes, and how providers can overcome the stigma.
11/01/2019
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
Susan S. Jacobs, RN, MS, on the New Guidelines for Home Oxygen Therapy
12/06/2020
In this podcast, Susan Jacobs, RN, MS, talks about the new American Thoracic Society's Guidelines on Home Oxygen Therapy, what they mean for clinicians and patients with COPD and ILD, as well as the highly...
12/06/2020
Diabetes
Diabetes
Ali Aminian, MD, on a New Tool for Bariatric Surgery Selection for Treating Diabetes
05/11/2017
Ali Aminian, MD, speaks about the development of his novel tool for bariatric surgery selection in treating diabetes, which was a result of his latest research.
05/11/2017
Cardiovascular Diseases
Cardiovascular Diseases
Laxmi Mehta, MD, on Preventing, Treating Myocardial Infarction in Women
02/01/2019
Dr Laxmi Mehta, from Ohio State University, talks about how treatment options differ between men and women who present with myocardial infarction and how to prevent a subsequent infarction.
02/01/2019